#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Hypersensitivity pneumonitis Small intestine neuroendocrine tumour Gestational trophoblastic tumour Extra-osseous Ewing's sarcoma Carcinoid syndrome Oesophageal adenocarcinoma stage II Acute graft versus host disease in liver Thromboangiitis obliterans Hyperoxaluria Skin cancer Prolymphocytic leukaemia Hypergammaglobulinaemia benign monoclonal Enteritis Rectal cancer More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome Sarcoidosis – Basic Information Mantle cell lymphoma stage III – Treatment Pleural mesothelioma malignant – Life with Disease Familial amyotrophic lateral sclerosis – Diagnostics Urea cycle disorder – Treatment Isodicentric chromosome 15 syndrome – Treatment Rhabdoid tumour Myelodysplastic syndrome with excess blasts – Treatment Urea cycle disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rilpivirine Hydrochloride Epirubicin RPTR-1-201 Hepatitis B Surface Antigen ASP3082 Azithromycin Dihydrate Pyrazinamide Iptacopan Safinamide Relugolix Melphalan Satoreotide Tetraxetan Thiocolchicoside Platelet Concentrate HTL0022537 Fenoterol Hydrobromide Labetalol Hydrochloride Gallium (68Ga) Gozetotide Venlafaxine Hydrochloride Pioglitazone Hydrochloride More therapies…

    Learn about Your Condition

    Pancoast's tumour Autoimmune hepatitis Skin bacterial infection Muscle hypertrophy Mental disorder Benign neoplasm of ureter Metastatic malignant melanoma Noninfective chorioretinitis Glioblastoma multiforme Retinal neovascularisation Cutaneous calcification Autoimmune haemolytic anaemia Hyperlipidaemia Rasmussen encephalitis Epiphysiolysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Medic Trials ST UG (haftungsbeschraenkt)

Medic Trials ST UG (haftungsbeschraenkt)

Heinz-Galinski-Strasse 1, Wedding, Berlin, 13347, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Germany Hungary Italy +5

  • Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    • Influenza Virus B/Michigan/01/2021
    Belgium Finland Germany Spain

  • Study of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26)
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    Belgium Germany

  • Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Bulgaria Czechia Germany Hungary Poland Slovakia +1

  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus bronchiolitis
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Germany

  • Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus bronchiolitis
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Belgium Estonia Finland Germany Italy Poland +1

  • Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    Austria Belgium Bulgaria Czechia Denmark France +8
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!